NCT04570956 2026-01-23
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk
Mayo Clinic
Phase 2 Terminated
Mayo Clinic
Seattle Institute for Biomedical and Clinical Research
The Center for Clinical and Cosmetic Research
University of Louisville
Rochester Skin Lymphoma Medical Group, PLLC
Rady Children's Hospital, San Diego
Fox Chase Cancer Center